To investigate whether cathepsin release from lysosomes contributes to cell death, we treated the CLL cells with a pan-cathepsin inhibitor, E-64, and subsequently treated them with siramesine and venetoclax alone and in combination. Here, CTSS is linked to B-cell chronic lymphocytic leukemia.